Anticipatory medication guide history

Document Title

Anticipatory Medication Guidelines

Document Date

March 2024

Document Purpose and Intended Audience

The aim of these guidelines is to ensure staff are informed and and Intended able to manage patients symptoms at the end of life Audience These guidelines are suitable for use in both primary community care and in the in-patient setting


Dr Anna Lock, Palliative Medicine Consultant, Sandwell and West Birmingham Hospitals NHS Trust
Michelle Aslett,
Specialist Palliative Care Pharmacist, Marie Curie

Consultation Process

Reviewed by SPAGG and ratified


This will be audited and reviewed every 3 years

Review Date

(must be within three years)

April 2027 ???

Approval Signatures:

SPAGG chair

Dr Jon Tomas

SPAGG secretary

Dr Alice Gray

Date Approved by SPAGG: March 2024??

Date submitted to Area Prescribing Committee: N/A

Version History

Version 1


March 2024

Summary of change/ process

(something about bringing 3 guides into one?)

Disclaimer (SPAGG - Rewrite)

This Guide is intended for use by healthcare professionals and the expectation is that they will use clinical judgement, medical, and nursing knowledge in applying the general principles and recommendations contained within. They are not meant to replace the many available texts on the subject of palliative care.

Some of the management strategies describe the use of drugs outside their licensed indications. They are, however, established and accepted good practice. Please refer to the current BNF for further guidance.

While WMPCPS takes every care to compile accurate information , we cannot guarantee its correctness and completeness and it is subject to change. We do not accept responsibility for any loss, damage or expense resulting from the use of this information.